Your session is about to expire
← Back to Search
N-Acetylcysteine for Lymphoma
Study Summary
This trial is testing the safety of a new drug, N-AC, when given with Yescarta to people with lymphoma. Different doses of N-AC will be tested to find the highest dose that is well tolerated by participants.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 3 trial • 302 Patients • NCT01675661Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I will be treated with axicabtagene ciloleucel for my lymphoma.
- Group 1: Participants with Lymphoma, Cohort 1
- Group 2: Participants with Lymphoma, Cohort 2
- Group 3: Participants with Lymphoma, Cohort 3
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the key indications for N-Acetylcysteine?
"N-Acetylcysteine has been known to successfully treat corneal ulceration, as well as a range of other ailments including acute rhinitis, acetaminophen poisoning, and various corneal diseases."
Has the Federal Drug Administration (FDA) sanctioned N-Acetylcysteine?
"Considering the scant evidence available, our team has assigned N-Acetylcysteine a 1 on the safety scale due to it being in Phase 1 of its clinical trials."
Are individuals with the relevant condition able to join this investigation?
"Affirmative. According to the clinicaltrials.gov website, this experiment is actively recruiting participants since its inception on 12th of August 2021 and most recent update taking place 24th of August 2022. 32 patients must be sourced from 1 separate medical centre in order for it to succeed."
Has N-Acetylcysteine been previously tested as part of a clinical trial?
"Currently, there are 38 active clinical trials for N-Acetylcysteine with 7 studies in Phase 3. Primarily based in New york State, these 44 trial sites span the United States."
How many subjects are being monitored in this clinical experiment?
"Affirmative. The clinicaltrial.gov portal reveals that this experiment, which was first inaugurated on December 8th 2021, is actively enrolling participants. A total of 32 individuals need to be enrolled from one medical centre."
Share this study with friends
Copy Link
Messenger